Lowcytometric S-phase fraction, but not ploidy nor hormmonal receptor status predicts survival in brazilian patients with operable breast cancer (2002)
- Authors:
- USP affiliated authors: FOLGUEIRA, MARIA APARECIDA AZEVEDO KOIKE - FM ; BRENTANI, MARIA MITZI - FM ; FEDERICO, MIRIAM HATSUE HONDA - FM
- Unidade: FM
- Subjects: NEOPLASIAS MAMÁRIAS (RADIOTERAPIA); NEOPLASIAS MAMÁRIAS ( QUIMIOTERAPIA); QUIMIOTERAPIA ADJUVANTE; CITOMETRIA DE FLUXO; PROGNÓSTICO
- Language: Inglês
- Imprenta:
- Source:
- Título: International Journal of Cancer
- ISSN: 0020-7136
- Volume/Número/Paginação/Ano: supl. 13, p. 205, res. P201, 2002
- Conference titles: UICC International Cancer Congress
-
ABNT
SNITCOVSKY, I. M. L. et al. Lowcytometric S-phase fraction, but not ploidy nor hormmonal receptor status predicts survival in brazilian patients with operable breast cancer. International Journal of Cancer. New York: Faculdade de Medicina, Universidade de São Paulo. . Acesso em: 29 dez. 2025. , 2002 -
APA
Snitcovsky, I. M. L., Folgueira, M. A. A. K., Mourão, M., Fassolas, G., Brentani, M. M., & Federico, M. H. H. (2002). Lowcytometric S-phase fraction, but not ploidy nor hormmonal receptor status predicts survival in brazilian patients with operable breast cancer. International Journal of Cancer. New York: Faculdade de Medicina, Universidade de São Paulo. -
NLM
Snitcovsky IML, Folgueira MAAK, Mourão M, Fassolas G, Brentani MM, Federico MHH. Lowcytometric S-phase fraction, but not ploidy nor hormmonal receptor status predicts survival in brazilian patients with operable breast cancer. International Journal of Cancer. 2002 ; 205.[citado 2025 dez. 29 ] -
Vancouver
Snitcovsky IML, Folgueira MAAK, Mourão M, Fassolas G, Brentani MM, Federico MHH. Lowcytometric S-phase fraction, but not ploidy nor hormmonal receptor status predicts survival in brazilian patients with operable breast cancer. International Journal of Cancer. 2002 ; 205.[citado 2025 dez. 29 ] - Doxorubicin, bleomycin, vincristine (ABV) or etoposide chemotherapy in AIDS: related poor risk Kaposi's sarcoma
- 1,25 dihydroxicitamin d3 receptor expression during differentiation of mammary and myeloid leukemic and cells
- Flow-cytometric dna analysis and hormonal receptor status in brazilian breast cancer patients
- C-ERBB-2 negativo após quimioterapia neoadjuvante (QN) prediz sobrevida livre de doença (SLD) mais longa em pacientes com câncer de mama
- Tumor infiltrating lymphocytes express cd 1 b and beta4 integrin chain
- Flow-cytometric DNA analysis and hormonal receptor status in brazilian breast cancer patients
- Disease free survical in breast cancer with high flowcytometric S phase fraction in Brazilian patients
- Thymocyte subpopulations and clonality in myasthenia gravis
- Carboplatin and etoposide (PE) combined with vincristine (V)-doxorubicin(AD)-cyclophosphamide (C) (VAdc) in ewing´s sarcoma (ES) primitive neuroectodermal tumor (PNET) in adults
- Casing a low c-erb-B2 expression after primary chemotherapy (PCT) predicts longer disease-free survival (DFS) in Brazilian patients with primary breast cancer
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
